Cost-Effective Excellence
In China, surgical and treatment costs are typically 40–70% lower than in the U.S./Western Europe (industry research).
- Non-profit public hospitals deliver the vast majority of inpatient/outpatient services, with scale lowering unit costs while protecting quality and access.
- National volume-based procurement (VBP) further reduces clinical costs — average coronary stent price from ~¥13,000 to ~¥700; average joint prosthesis price down ≈80%.